Is Hydroquinone safe in cosmetics?
Hydroquinone has a safety rating of "POOR" in our database. EU status: prohibited. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Also known as: 1,4-Benzenediol, Dihydroxybenzene, Benzene, p-dihydroxy-, Black and White Bleaching Cream, Derma-Blanch (+14 more)
INCI: HYDROQUINONE
Hydroquinone (CAS 123-31-9) is a cosmetic active ingredient functioning as Tyrosinase inhibitor; competitive inhibitor and cytotoxic agent to melanocytes;. NOAEL 20 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: prohibited. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
Hydroquinone is prohibited in EU cosmetics but has active industrial GHS classifications (H302, H312, H317, H318, H341, H351, H400, H410).
Source: Cosmetics: ingredients.eu status; Chemicals: ghs classifications.signal word/hazard statement code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Hydroquinone.
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for Hydroquinone. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =3840 mg/kg | dermal | rat | general toxicity | CIR Safety Assessment |
| NOAEL | =3840 mg/kg | dermal | rat | general toxicity | CIR Safety Assessment |
| NOAEL | =3840 mg/kg | dermal | rat | general toxicity | CIR Safety Assessment |
| NOAEL | =3840 mg/kg | dermal | rat | general toxicity | CIR Safety Assessment |
| NOAEL | =4800 mg/kg | dermal | mouse | general toxicity | CIR Safety Assessment |
| NOAEL | =4800 mg/kg | dermal | mouse | general toxicity | CIR Safety Assessment |
| NOAEL | =4800 mg/kg | dermal | mouse | general toxicity | CIR Safety Assessment |
| NOAEL | =4800 mg/kg | dermal | mouse | general toxicity | CIR Safety Assessment |
| NOAEL | =73.9 mg/kg bw/day | dermal | Rat | subchronic | ECHA |
| NOAEL | =109.6 mg/kg bw/day | dermal | Rat | subchronic | ECHA |
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Pre-calculated NOAEL → SED → MoS audit trail for Hydroquinone across SCCS product categories, with measured dermal absorption where available.
Contact sensitization data for Hydroquinone based on clinical patch test studies and IFRA standards.
Source: IVDK; NACDG; ESSCA
Skin absorption and penetration characteristics of Hydroquinone, relevant to systemic exposure and MoS calculations.
Source: SCCS Opinion
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LOEL | =64 mg/kg-day | Rat | oral | chronic | ECOTOX |
| NOEL | =20 mg/kg-day | Rat | oral | chronic | ECOTOX |
| NOEL | =120 mg/kg-day | Mouse | oral | short-term | ECOTOX |
| LD50 | =320 mg/kg | Rat | oral | acute | NIOSH IDLH |
| LD50 | =200 mg/kg | Dog | oral | acute | NIOSH IDLH |
| LD50 | =70 mg/kg | Cat | oral | acute | NIOSH IDLH |
| NOEL | =150 mg/kg-day | Rat | oral | chronic | ECOTOX |
| NOEL | =150 mg/kg-day | Rat | oral | chronic | ECOTOX |
| NOEL | =15 mg/kg-day | Rat | oral | chronic | ECOTOX |
| NOEL | =150 mg/kg-day | Rat | oral | chronic | ECOTOX |
International Agency for Research on Cancer (WHO) monograph evaluation.
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Inserted via ATP: ATP01
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: LLNA: Lea (1999) | Kimber et al. (1998); DPRA: Natsch et al. 2013 [DOI:10.1002/jat.2868] | Nukada et al. 2013 [DOI:10.1016/j.tiv.2012.11.006]; KS: Natsch et al. 2013 [DOI:10.1002/jat.2868]; hCLAT: Ashikaga et al. 2010 [DOI:10.1177/026119291003800403] | Sakaguchi et al. 2010 [DOI:10.1016/j.tiv.2010.05.012]
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
modulator; aryl hydrocarbon receptor agonist
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| CN | banned | - | - |
| CN | restricted | 0.3 | Oxidative hair dye products only |
| CN | permitted_hair_dye | 0.3 | Oxidative hair dye ONLY |
| IN | banned | - | all OTC cosmetics — drug classification |
| IN | drug_classification | - | skin-lightening / fairness products |
| AU | restricted | 2.0 | skin lightening |
| GCC | banned | - | All cosmetics |
| SA | banned | - | All cosmetic products |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
Source: EPA Dryad Skin Absorption 2024
Source: Roberts Cheruvu Mendeley 2022
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_in_vitro | 11.0 | In vivo — clinical (urine excretion) In vitro — Franz cells | - | Bucks et al. 1988; CIR Amended SA 2014 (1988) |
| measured_in_vitro | 42.5 | - | - | SCCS/1444/11 |
Preliminary editorial summary for Hydroquinone — not a computed safety verdict. See the sourced toxicological data above.
Public NOAEL study rows linked to Hydroquinone by CAS number or substance name.
Units vary across source rows: mg/kg bw/day, mg/kg
| Absorption % | Method | Vehicle |
|---|---|---|
| 11.0 | In vivo — clinical (urine excretion) In vitro — Franz cells | Aqueous solution (in vivo); Various |
| 42.5 | - | - |
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Hydroquinone has a safety rating of "POOR" in our database. EU status: prohibited. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Hydroquinone EU regulatory status: prohibited. This is based on EU Regulation 1223/2009 and its amendments.
Hydroquinone functions as: Tyrosinase inhibitor; competitive inhibitor and cytotoxic agent to melanocytes; inhibits both melanin synthesis and DNA synthesis in melanocytes; benchmark for all modern depigmenting actives. It is classified as a Active Ingredient in our database. CAS number: 123-31-9.
The NOAEL (No Observed Adverse Effect Level) for Hydroquinone is =3840 mg/kg based on a general toxicity study via dermal route in rat. A total of 10 study endpoints are available. Source: CIR Safety Assessment.
Hydroquinone also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Hydroquinone is prohibited in EU cosmetics but has active industrial GHS classifications (H302, H312, H317, H318, H341, H351, H400, H410).
Check Hydroquinone compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Hydroquinone in your formulation.